TABLE IX.A.1.
Evidence of the effectiveness of house dust mite avoidance and environmental controls in the management of allergic rhinitis
Study | Year | LOE | Study design | Study groups | Clinical endpoint | Conclusion |
---|---|---|---|---|---|---|
Sheikh et al.1126 | 2010 | 1a | SR | RCTs examining the effectiveness of environmental measures for HDM | Symptoms | Acaricides are the most effective as a single measure or in combination with other measures to decrease HDM and improve symptoms. |
Ghazala et al.1120 | 2004 | 1b | Randomized crossover study |
|
Allergen content (Der p 1, Der f 1, mite group 2), subjective clinical complaints | Impermeable encasings significantly reduce allergen concentration, without difference in subjective symptom scores. |
Terreehorst et al.1124 | 2003 | 1b | Double-blind RCT |
|
Rhinitis-specific visual analogue scale, daily symptom score, nasal allergen provocation, Der p 1 and Der f 1 concentration | Impermeable encasings significantly reduce allergen concentration, without difference in symptoms or nasal provocation testing. |
Nurmatov et al.1114 | 2012 | 2a | SR of RCTs |
|
HDM load, symptom scores, medication scores, disease-specific QOL | Environmental controls significantly reduced HDM load. Acaricides most effective single method. Combination therapies more effective than single interventions and may offer symptom relief. |
Stillerman et al.1127 | 2010 | 2b | RDBPCT, crossover |
|
Reported nasal symptoms, QOL scores using the nocturnal RQLQ | PAF is associated with improved nasal symptom and QOL scores. |
Brehler & Kneist1128 | 2006 | 2b | RDBPCT, parallel-group |
|
Allergy symptom scores, use of anti-allergic medication | HDM-impermeable bedding is associated with significant reduction in symptom scores without change in anti-allergic drug utilization. |
Moon & Choi1122 | 1999 | 2b | Open RCT |
|
Change in HDM load, daily rhinitis symptom scores | Multimodality environmental control is associated with reductions in mean dust mite concentration and nasal symptom scores. |
Geller-Bernstein et al.1119 | 1995 | 2b | Double-blind RCT |
|
Daily rhinitis and asthma symptom scores, medication use, twice-weekly PEF | Acaricide is associated with decreased mean symptom scores. |
Kniest et al.1121 | 1992 | 2b | Double-blind matched pair controlled trial |
|
Daily symptoms and medication scores, physician assessment, tIgE, sIgE, serum and nasal eosinophils, guanine exposure | Acaricide associated with improvement in all outcome measures except for mite-specific IgE. |
Antonicelli et al.1125 | 1991 | 2b | Randomized crossover study |
|
HDM concentration, rhinitis and asthma symptom score | HEPA filtration had no significant effect on rhinitis symptom scores. |
Reisman et al.1123 | 1990 | 2b | Double-blind crossover RCT |
|
Particulate counts in bedroom air, symptom and medication scores, patients’ subjective response to treatment | HEPA filtration is associated with improved particulate counts and symptom/medication scores. |
HDM = house dust mite; HEPA = high-efficiency particulate air; IgE = immunoglobulin E; LOE = level of evidence; PAF = personal air filtration; PEF = peak expiratory flow; QOL = quality of life; RCT = randomized controlled trial; RDBPCT = randomized double-blind-placebo-controlled trial; RQLQ; Rhinoconjunctivitis Quality of Life Questionnaire; sIgE = antigen specific immunoglobulin E; SR = systematic review; tIgE = total immunoglobulin E.